/ /

  • linkedin
  • Increase Font
  • Sharebar

    Glaucoma experiences transformative growth as a subspecialty

    Renaissance features innovative diagnostic and therapeutic tools to improve disease management


    Glaucoma renaissance men

    Dr. Singh pointed out that as with the European Renaissance, a few individuals were critical to the field moving forward. He particularly praised the work of two, now-deceased clinician scientists: Carl Camras, MD, and Thom Zimmerman, MD, as pioneers in bringing about the Glaucoma Renaissance.

    Dr. Camras performed work that ultimately led to the development of prostaglandin analogs–although he had to partner with a European-based company because of the lack of initial interest from corporate partners in the United States.

    Dr. Zimmerman, besides giving the specialty timolol as a treatment to lower intraocular pressure (IOP), was among the first clinicians to pose the idea of a safer, non-penetrating operation for glaucoma–deep sclerectomy. This was the stimulus for further research that influenced the MIGS revolution, Dr. Singh said.

    While for most of the 20th century, glaucoma was considered a field with few safe and effective surgical treatment options, today, there are up to 17 distinct ways to lower IOP without medications, said Dr. Singh.


    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results